Literature DB >> 18264805

Inherited and acquired risk factors for arterial ischemic stroke in childhood.

Giuseppe Lippi1, Massimo Franchini, Martina Montagnana, Gian Luca Salvagno, Giovanni Targher, Gian Cesare Guidi.   

Abstract

Ischemic stroke in childhood is a rare but serious disorder, which is associated with significant morbidity and mortality. The lack of causal homogeneity in the aetiology of this disorder presents problems for predicting and preventing it, making the ischemic stroke in childhood a real dilemma for the clinician. Although a variety of potential inherited and acquired causes have been now identified, including cardiac pathologies, infections, prothrombotic, metabolic and vascular disorders, the aetiology of ischemic stroke in the young remains still unknown in more than one third of the patients. Presently, an appropriate evaluation of some hypercoagulable conditions seems justified in adults with stroke. However, the etiologic contribution of several thrombophilic conditions to initial and recurrent stroke in affected children has not been definitely clarified, since more powerful and influential non-thrombophilic risk factors are usually present, making the thrombophilia screening in such circumstance a matter of debate. In particular, the diagnostic yield of the screening is reportedly lower in children, the role of several prothrombotic abnormalities is uncertain, especially in recurrent stroke, and there is no evidence-based guidance to stroke prevention and therapy in children carrying a hypercoagulable state. Additional studies are needed to quantify the risk for a cerebrovascular event in children with a prothrombotic disorder and to determine which combination of endogenous and exogenous risk factors leads to greater rates of initial and recurrent stroke.

Entities:  

Mesh:

Year:  2008        PMID: 18264805     DOI: 10.1007/s11239-008-0202-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  92 in total

1.  Prothrombotic risk factors in childhood stroke and venous thrombosis.

Authors:  C Heller; S Becker; I Scharrer; W Kreuz
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

2.  Thrombophilic disorders in children with cerebral infarction.

Authors:  S Becker; C Heller; F Gropp; I Scharrer; W Kreuz
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

3.  Occlusion of large cerebral vessels in sickle-cell anemia.

Authors:  J A Stockman; M A Nigro; M M Mishkin; F A Oski
Journal:  N Engl J Med       Date:  1972-10-26       Impact factor: 91.245

4.  Factor V Leiden, prothrombin 20210G-->A and the MTHFR C677T mutations in childhood stroke.

Authors:  M D McColl; E A Chalmers; A Thomas; A Sproul; C Healey; I Rafferty; R McWilliam; P Eunson
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

5.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

Review 6.  Prothrombotic abnormalities in childhood ischaemic stroke.

Authors:  Chris Barnes; Gabrielle Deveber
Journal:  Thromb Res       Date:  2005-07-21       Impact factor: 3.944

Review 7.  Therapy insight: stroke risk and its management in patients with sickle cell disease.

Authors:  Fenella J Kirkham
Journal:  Nat Clin Pract Neurol       Date:  2007-05

8.  High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia.

Authors:  L Angelini; A Ravelli; R Caporali; V Rumi; N Nardocci; A Martini
Journal:  Pediatrics       Date:  1994-10       Impact factor: 7.124

9.  Mendelian and mitochondrial disorders associated with stroke.

Authors:  Scott Silliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2002 Sep-Oct       Impact factor: 2.136

10.  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Iacopo Olivotto; Pietro Bellone; Maria Rosa Conte; Franco Cecchi; Björn P Flygenring; Susan A Casey; Thomas E Gohman; Sergio Bongioanni; Paolo Spirito
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.